Copyright Reports & Markets. All rights reserved.

Global Pet Drug and Vaccine Market Size, Status and Forecast 2021-2027

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Pet Drug and Vaccine Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
    • 1.2.2 Drugs
    • 1.2.3 Vaccine
  • 1.3 Market by Application
    • 1.3.1 Global Pet Drug and Vaccine Market Share by Application: 2016 VS 2021 VS 2027
    • 1.3.2 Dogs
    • 1.3.3 Cats
    • 1.3.4 Other
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Pet Drug and Vaccine Market Perspective (2016-2027)
  • 2.2 Pet Drug and Vaccine Growth Trends by Regions
    • 2.2.1 Pet Drug and Vaccine Market Size by Regions: 2016 VS 2021 VS 2027
    • 2.2.2 Pet Drug and Vaccine Historic Market Share by Regions (2016-2021)
    • 2.2.3 Pet Drug and Vaccine Forecasted Market Size by Regions (2022-2027)
  • 2.3 Pet Drug and Vaccine Industry Dynamic
    • 2.3.1 Pet Drug and Vaccine Market Trends
    • 2.3.2 Pet Drug and Vaccine Market Drivers
    • 2.3.3 Pet Drug and Vaccine Market Challenges
    • 2.3.4 Pet Drug and Vaccine Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Pet Drug and Vaccine Players by Revenue
    • 3.1.1 Global Top Pet Drug and Vaccine Players by Revenue (2016-2021)
    • 3.1.2 Global Pet Drug and Vaccine Revenue Market Share by Players (2016-2021)
  • 3.2 Global Pet Drug and Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Pet Drug and Vaccine Revenue
  • 3.4 Global Pet Drug and Vaccine Market Concentration Ratio
    • 3.4.1 Global Pet Drug and Vaccine Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Pet Drug and Vaccine Revenue in 2020
  • 3.5 Pet Drug and Vaccine Key Players Head office and Area Served
  • 3.6 Key Players Pet Drug and Vaccine Product Solution and Service
  • 3.7 Date of Enter into Pet Drug and Vaccine Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Pet Drug and Vaccine Breakdown Data by Type

  • 4.1 Global Pet Drug and Vaccine Historic Market Size by Type (2016-2021)
  • 4.2 Global Pet Drug and Vaccine Forecasted Market Size by Type (2022-2027)

5 Pet Drug and Vaccine Breakdown Data by Application

  • 5.1 Global Pet Drug and Vaccine Historic Market Size by Application (2016-2021)
  • 5.2 Global Pet Drug and Vaccine Forecasted Market Size by Application (2022-2027)

6 North America

  • 6.1 North America Pet Drug and Vaccine Market Size (2016-2027)
  • 6.2 North America Pet Drug and Vaccine Market Size by Type
    • 6.2.1 North America Pet Drug and Vaccine Market Size by Type (2016-2021)
    • 6.2.2 North America Pet Drug and Vaccine Market Size by Type (2022-2027)
    • 6.2.3 North America Pet Drug and Vaccine Market Size by Type (2016-2027)
  • 6.3 North America Pet Drug and Vaccine Market Size by Application
    • 6.3.1 North America Pet Drug and Vaccine Market Size by Application (2016-2021)
    • 6.3.2 North America Pet Drug and Vaccine Market Size by Application (2022-2027)
    • 6.3.3 North America Pet Drug and Vaccine Market Size by Application (2016-2027)
  • 6.4 North America Pet Drug and Vaccine Market Size by Country
    • 6.4.1 North America Pet Drug and Vaccine Market Size by Country (2016-2021)
    • 6.4.2 North America Pet Drug and Vaccine Market Size by Country (2022-2027)
    • 6.4.3 United States
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe Pet Drug and Vaccine Market Size (2016-2027)
  • 7.2 Europe Pet Drug and Vaccine Market Size by Type
    • 7.2.1 Europe Pet Drug and Vaccine Market Size by Type (2016-2021)
    • 7.2.2 Europe Pet Drug and Vaccine Market Size by Type (2022-2027)
    • 7.2.3 Europe Pet Drug and Vaccine Market Size by Type (2016-2027)
  • 7.3 Europe Pet Drug and Vaccine Market Size by Application
    • 7.3.1 Europe Pet Drug and Vaccine Market Size by Application (2016-2021)
    • 7.3.2 Europe Pet Drug and Vaccine Market Size by Application (2022-2027)
    • 7.3.3 Europe Pet Drug and Vaccine Market Size by Application (2016-2027)
  • 7.4 Europe Pet Drug and Vaccine Market Size by Country
    • 7.4.1 Europe Pet Drug and Vaccine Market Size by Country (2016-2021)
    • 7.4.2 Europe Pet Drug and Vaccine Market Size by Country (2022-2027)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific Pet Drug and Vaccine Market Size (2016-2027)
  • 8.2 Asia-Pacific Pet Drug and Vaccine Market Size by Type
    • 8.2.1 Asia-Pacific Pet Drug and Vaccine Market Size by Type (2016-2021)
    • 8.2.2 Asia-Pacific Pet Drug and Vaccine Market Size by Type (2022-2027)
    • 8.2.3 Asia-Pacific Pet Drug and Vaccine Market Size by Type (2016-2027)
  • 8.3 Asia-Pacific Pet Drug and Vaccine Market Size by Application
    • 8.3.1 Asia-Pacific Pet Drug and Vaccine Market Size by Application (2016-2021)
    • 8.3.2 Asia-Pacific Pet Drug and Vaccine Market Size by Application (2022-2027)
    • 8.3.3 Asia-Pacific Pet Drug and Vaccine Market Size by Application (2016-2027)
  • 8.4 Asia-Pacific Pet Drug and Vaccine Market Size by Region
    • 8.4.1 Asia-Pacific Pet Drug and Vaccine Market Size by Region (2016-2021)
    • 8.4.2 Asia-Pacific Pet Drug and Vaccine Market Size by Region (2022-2027)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Pet Drug and Vaccine Market Size (2016-2027)
  • 9.2 Latin America Pet Drug and Vaccine Market Size by Type
    • 9.2.1 Latin America Pet Drug and Vaccine Market Size by Type (2016-2021)
    • 9.2.2 Latin America Pet Drug and Vaccine Market Size by Type (2022-2027)
    • 9.2.3 Latin America Pet Drug and Vaccine Market Size by Type (2016-2027)
  • 9.3 Latin America Pet Drug and Vaccine Market Size by Application
    • 9.3.1 Latin America Pet Drug and Vaccine Market Size by Application (2016-2021)
    • 9.3.2 Latin America Pet Drug and Vaccine Market Size by Application (2022-2027)
    • 9.3.3 Latin America Pet Drug and Vaccine Market Size by Application (2016-2027)
  • 9.4 Latin America Pet Drug and Vaccine Market Size by Country
    • 9.4.1 Latin America Pet Drug and Vaccine Market Size by Country (2016-2021)
    • 9.4.2 Latin America Pet Drug and Vaccine Market Size by Country (2022-2027)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Pet Drug and Vaccine Market Size (2016-2027)
  • 10.2 Middle East & Africa Pet Drug and Vaccine Market Size by Type
    • 10.2.1 Middle East & Africa Pet Drug and Vaccine Market Size by Type (2016-2021)
    • 10.2.2 Middle East & Africa Pet Drug and Vaccine Market Size by Type (2022-2027)
    • 10.2.3 Middle East & Africa Pet Drug and Vaccine Market Size by Type (2016-2027)
  • 10.3 Middle East & Africa Pet Drug and Vaccine Market Size by Application
    • 10.3.1 Middle East & Africa Pet Drug and Vaccine Market Size by Application (2016-2021)
    • 10.3.2 Middle East & Africa Pet Drug and Vaccine Market Size by Application (2022-2027)
    • 10.3.3 Middle East & Africa Pet Drug and Vaccine Market Size by Application (2016-2027)
  • 10.4 Middle East & Africa Pet Drug and Vaccine Market Size by Country
    • 10.4.1 Middle East & Africa Pet Drug and Vaccine Market Size by Country (2016-2021)
    • 10.4.2 Middle East & Africa Pet Drug and Vaccine Market Size by Country (2022-2027)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Zoetis
    • 11.1.1 Zoetis Company Details
    • 11.1.2 Zoetis Business Overview
    • 11.1.3 Zoetis Pet Drug and Vaccine Introduction
    • 11.1.4 Zoetis Revenue in Pet Drug and Vaccine Business (2016-2021)
    • 11.1.5 Zoetis Recent Development
  • 11.2 Boehringer Ingelheim
    • 11.2.1 Boehringer Ingelheim Company Details
    • 11.2.2 Boehringer Ingelheim Business Overview
    • 11.2.3 Boehringer Ingelheim Pet Drug and Vaccine Introduction
    • 11.2.4 Boehringer Ingelheim Revenue in Pet Drug and Vaccine Business (2016-2021)
    • 11.2.5 Boehringer Ingelheim Recent Development
  • 11.3 Merck Animal Health
    • 11.3.1 Merck Animal Health Company Details
    • 11.3.2 Merck Animal Health Business Overview
    • 11.3.3 Merck Animal Health Pet Drug and Vaccine Introduction
    • 11.3.4 Merck Animal Health Revenue in Pet Drug and Vaccine Business (2016-2021)
    • 11.3.5 Merck Animal Health Recent Development
  • 11.4 Elanco Animal Health
    • 11.4.1 Elanco Animal Health Company Details
    • 11.4.2 Elanco Animal Health Business Overview
    • 11.4.3 Elanco Animal Health Pet Drug and Vaccine Introduction
    • 11.4.4 Elanco Animal Health Revenue in Pet Drug and Vaccine Business (2016-2021)
    • 11.4.5 Elanco Animal Health Recent Development
  • 11.5 Virbac
    • 11.5.1 Virbac Company Details
    • 11.5.2 Virbac Business Overview
    • 11.5.3 Virbac Pet Drug and Vaccine Introduction
    • 11.5.4 Virbac Revenue in Pet Drug and Vaccine Business (2016-2021)
    • 11.5.5 Virbac Recent Development
  • 11.6 Dechra Veterinary Products
    • 11.6.1 Dechra Veterinary Products Company Details
    • 11.6.2 Dechra Veterinary Products Business Overview
    • 11.6.3 Dechra Veterinary Products Pet Drug and Vaccine Introduction
    • 11.6.4 Dechra Veterinary Products Revenue in Pet Drug and Vaccine Business (2016-2021)
    • 11.6.5 Dechra Veterinary Products Recent Development
  • 11.7 Ceva
    • 11.7.1 Ceva Company Details
    • 11.7.2 Ceva Business Overview
    • 11.7.3 Ceva Pet Drug and Vaccine Introduction
    • 11.7.4 Ceva Revenue in Pet Drug and Vaccine Business (2016-2021)
    • 11.7.5 Ceva Recent Development
  • 11.8 Vetoquinol
    • 11.8.1 Vetoquinol Company Details
    • 11.8.2 Vetoquinol Business Overview
    • 11.8.3 Vetoquinol Pet Drug and Vaccine Introduction
    • 11.8.4 Vetoquinol Revenue in Pet Drug and Vaccine Business (2016-2021)
    • 11.8.5 Vetoquinol Recent Development
  • 11.9 Meiji
    • 11.9.1 Meiji Company Details
    • 11.9.2 Meiji Business Overview
    • 11.9.3 Meiji Pet Drug and Vaccine Introduction
    • 11.9.4 Meiji Revenue in Pet Drug and Vaccine Business (2016-2021)
    • 11.9.5 Meiji Recent Development
  • 11.10 Ouro Fino Saude
    • 11.10.1 Ouro Fino Saude Company Details
    • 11.10.2 Ouro Fino Saude Business Overview
    • 11.10.3 Ouro Fino Saude Pet Drug and Vaccine Introduction
    • 11.10.4 Ouro Fino Saude Revenue in Pet Drug and Vaccine Business (2016-2021)
    • 11.10.5 Ouro Fino Saude Recent Development
  • 11.11 Parnell
    • 11.11.1 Parnell Company Details
    • 11.11.2 Parnell Business Overview
    • 11.11.3 Parnell Pet Drug and Vaccine Introduction
    • 11.11.4 Parnell Revenue in Pet Drug and Vaccine Business (2016-2021)
    • 11.11.5 Parnell Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Pet Drug and Vaccine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Pet Drug and Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

    Segment by Type
    Drugs
    Vaccine

    Segment by Application
    Dogs
    Cats
    Other

    By Region
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia
    Latin America
    Mexico
    Brazil
    Rest of Latin America
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of MEA

    By Company
    Zoetis
    Boehringer Ingelheim
    Merck Animal Health
    Elanco Animal Health
    Virbac
    Dechra Veterinary Products
    Ceva
    Vetoquinol
    Meiji
    Ouro Fino Saude
    Parnell

    Buy now